On the Frontline of Exoskeleton; Ekso Bionics Analyst Report Issued by BrokerBank Securities, Inc.
23 Apr, 2015, 08:30 ET
NEW YORK, April 23, 2015 /PRNewswire/ -- There are significant number of applications for exoskeletons, from assisting paraplegics in healthcare, to increasing capabilities in military, and even increasing labor productivity in industry. Although bionic exoskeleton technology is still in its early stage, and can only be used in specific circumstances, recent advancements in material, electronic and electrical engineering, control technologies, and sensor and software development made improvements being started within the last few years.
Ekso Bionics Holdings, Inc. (OTCQB: EKSO) has been at the frontline of the bionic exoskeleton industry, and has helped make huge improvements in exoskeleton technology. It designs, develops and commercializes wearable "bionic human exoskeletons" that have a variety of applications in healthcare, industrial, military, and consumer markets. The company has products for medical, military, and even recreational use, making a concerted effort to cover all the promising exoskeleton markets.
Esko Bionics ended 2014 with medical device revenue increase by $1.3 million to $2.9 million, or 81%, compared to 2013, and engineering services revenue increase by $0.7 million to $2.4 million, or 42%, compared to 2013 with $25.2M in cash/cash equivalents.
For a more detailed report with analyst comments and recommendation on Ekso Bionics Holdings, Inc. please follow the link. There is no cost obligation required to view analyst report.
Copy and paste to browser may be required.
This report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this report have not been compensated in any form by profiled company. A full disclaimer can be found by viewing the full analyst report.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is written and authored by a 3rd party analyst. However, we are only human and make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.
SOURCE BrokerBank Securities, Inc.
Share this article